2. Academic Validation
  3. Improved Synthesis of MDL 73811 - a Potent AdoMetDC Inhibitor and Anti-Trypanosomal Compound

Improved Synthesis of MDL 73811 - a Potent AdoMetDC Inhibitor and Anti-Trypanosomal Compound

  • Synthesis (Stuttg). 2016 Jul;48(13):2065-2068. doi: 10.1055/s-0035-1561608.
Anthony J Brockway 1,  Casey C Cosner 1,  Oleg A Volkov 2,  Margaret A Phillips 2,  Jef K De Brabander 1
Affiliations

Affiliations

  • 1 Department of Biochemistry, The University of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Boulevard, Dallas, Texas 75390-9038, United States.
  • 2 Department of Pharmacology, The University of Texas Southwestern Medical Center at Dallas,6001 Forest Park Road, Dallas, Texas 75390-9041, United States.
PMID: 27482123 DOI: 10.1055/s-0035-1561608
Abstract

An improved synthesis of MDL 73811 - a potent AdoMetDC (S-adenosylmethionine decarboxylease) inhibitor and anti-trypanosomal compound with in vivo activity has been completed in four steps from commercially available 2',3'-O-isopropylideneadenosine. Utilization of Mitsunobu chemistry was crucial for the reliable and scalable introduction of the 5'-methylamine moiety, which was problematic using traditional activation/displacement chemistry as previously reported. All reactions in this synthesis were run on gram-scale resulting in a five-fold increase in yield over the original synthesis.

Keywords

drug discovery; nucleosides.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z